Introduction
An increasing burden of invasive fungal infections is being reported [1 -3] especially in patients receiving allo-Stem Cell Transplantations (allo-SCT) [4] and those in intensive care after trauma, surgery, or other invasive treatments. In particular, cases involving visceral mycoses are especially challenging in these patients who are at higher risk of infections [5 -11] . Although such infections should also be considered in many additional clinical settings, detailed reports on visceral mycoses found at autopsy in national surveys are lacking, despite the fact that this is the most defi nitive method for diagnosing fungal infections is pathological examination [12] . We have reported on the diagnosed by pathologists, several subcause s of death, and whether the subject had received an organ transplant. Mycoses were diagnosed by each institutional pathologist through the use of Hematoxylin-eosin (HE) staining and immunohistochemical staining (IHC) of autopsied organs, as well as byclinical information from physicians. Mycotic infections were diagnosed in the following manner, i.e., by detection at autopsy by HE and IHC, and those noted prior to death by culture and/or serum-based tests.
Identifi cation of etiologic agents was based on histopathological information and culture data from the reporting institution. All diagnosis were made by the respective institutional pathologists.
Diagnostic criteria
Mycoses are defi ned as infections caused by eumycotic organisms such as Candida, Aspergillus, Cryptococcus, Mucormycetes, Trichosporon, and others. Infections caused by fi lamentous bacteria such as Actinomycetes (Actinomyces, Nocardia, and Streptomyces spp.). and Pneumoncystis pneumonia were excluded in accord with the defi nition in our fi rst series of epidemiological research studies. Superfi cial infections such as dematophytoses were also excluded from the category of visceral mycoses. The term ' complicated infection ' refers to a mixed infection caused by two or more fungi.
Autopsy records were used to assess severe mycotic infections identifi ed as (i) the direct cause of death, (ii) causing pulmonary infection involving both lobes of the lung, (iii) infection of the central nervous system (CNS) together with one or more other organ system, (iv) systemic infection of three or more organ systems excluding the CNS, or (v) cases involving fungemia prior to the patient ' s death as indicated in the clinical records.
Statistic c 2 -testing was applied and P Յ 0.05 was taken as statistically signifi cant. All reported P -values are two severe aspergillosis and candidiasis tended to decrease since 2001 and 1997, respectively. In contrast, severe mucormycosis cases seem to have been stable at more than 70% since 1997 (Table 2) .
Considering the age of the patient at autopsy, aspergillosis and candidosis were the most common infections, with the former more prevalent in people Ն 40 years of age. Strikingly, members of the mucormycetes were the most frequent infectious fungal agents in 2009 in patients less than one year old (Table 3) . Mucormycoses had never been observed in patients less than one year old before 2009 and represented sporadic cases and did not come from the same institution.
The predominant foci of infection caused by single fungal pathogens were the respiratory system (318 cases), followed by blood (51), the urinary system (50) and systemic infections (34) ( Table 4) . Aspergillosis was predominant in the respiratory system (215; 71.9%) and systemic (13; 38.2%) infections. In the CNS ( n ϭ 19), cryptococcosis was the most common infection (13 (38.2%), whereas Candida was most frequent (26; 51%) in fungemia ( n ϭ 51).
Regarding underlying diseases, there were 134 patients with solid tumors (21.2%), 91 with leukemia sided. Analyses were performed using JMP version 9 software (SAS, Cary, NC, USA)
Results
In 2009, 13,787 cases (9,235 males) were autopsied, of which 633 (4.59%) were found to have fungal infections. Of these, a total of 610 (96.4%) were caused by only one pathogen, whereas the remaining 23 (3.6%) were complicated mycoses.
Among the 610 cases due to a single fungal pathogen, the predominant causative agents were Aspergillus spp. (299; 47.2%), following in order by Candida spp. (184; 29.1%), Cryptococcus spp. (35; 5.5%), and Mucormycetes (22; 3.5%). The frequency of aspergillosis has gradually increased since 1993, whereas the frequency of mucormycoses seemed to have remained quite stable since 1989. Infections caused by fungi that could not be indentifi ed were 10.4% in 2009, but for the fi rst time those involving rare fungal etiologic agents, i.e., Conidiobolus lamprauges , Scedosporium prolifi cans and Fusarium spp. appeared in our series of reports (Table 1) .
While the proportion of severe mycoses has been gradually increasing since 1993, the numbers of cases of and myelodysplastic syndrome (MDS) (14.4%), and 72 with lymphoma (11.4%) (Fig. 1) . A total of 28% (180) of patients had hematological malignancies including lymphoma, leukemia, MDS and myeloma. These represented the majority of underlying diseases associated with fungal infections (Fig. 1) . Furthermore, focusing only on patients with leukemia and MDS, aspergillosis and candidosis were predominant, followed by mucormycosis in 2009. Cryptococcosis was less common in leukemia and MDS cases (Table 5) , although the latter was the third most prevalent in the whole cohort.
Discussion
We have analyzed the epidemiology of visceral mycoses in autopsy cases in Japan by extracting data from the 2009 edition of the Annual of Pathological Autopsy Cases in Japan. Our fi rst conclusion is that their frequency, especially severe infection, has not decreased over the last 10 years. Mycoses are therefore still an important problem for the clinician. The second conclusion is that while the prevalence of severe aspergillosis is decreasing, it is still the predominant and the most important fungal infection. Third, we note that visceral mycoses caused by unidentifi ed organisms may be decreasing, due to the development of serum -based tests [13 -16] , and the increased efforts of clinicians and pathologists to diagnose them [17 -20] . Fourth, rare mycoses caused by such fungi as Fusarium spp. Conidiobolus lamprauges [21] , and Scedosporium prolifi cans [22, 23] are now being diagnosed. These have been reported as breakthrough infections after treatment with voriconazole [24] and other new agents [25] . Scedosporium prolifi cans was also reported as causing ' Tsunami lung ' after the Tohoku earthquake of 2011 [26] . Therefore, we should be on our guard and monitor the trends of scedosporiosis.
Finally, members of the Mucormycetes are seen as the etiologic agent of infections of infants younger than one year for the fi rst time in our series of reports and were in fact the most predominant fungal infection in this age group. According to Zaoutis ' s report of 157 children with mucormycosis, boys predominate, and disseminated disease and age Ͻ 1 year were independent risk factors for death (odds ratios 7.18 and 3.85, respectively) [27] . For hematologists, mucormycosis are the third most common fungal infections, which have gradually come to be recognized as breakthrough infections after antifungal therapy [28] . However, Parasad et al . did not observe an increase in the rate of mucormycosis over the time period of their study in their patient population, despite increasing use of voriconazole after its licensing in the USA [29] . Nonetheless, mucormycosis should remain the focus of attention in the pediatric fi eld. One limitation of the present study may be that epidemiology of autopsied cases does not include the less severe cases of fungal infection. It must also be borne in mind that only 1.2% of deceased individuals were autopsied in Japan in 2009. Nonetheless, epidemiological ana lysis of autopsied cases with fungal infection provides a strong incentive to intensify efforts to recognize and treat visceral mycoses.
